Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

Microsoft security researchers have discovered a new backdoor malware that uses the OpenAI Assistants API as a covert command ...

In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...

The National Reconstruction Fund Corporation (NRFC) has taken a $54 million stake in Australian medical device company Synchron, to support the production of minimally invasive Brain-Computer ...

Brain-computer interface (BCI) specialist Synchron has previewed an artificial intelligence model that it believes will form the basis of a new generation of devices to allow individuals to control ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...